Karl Butterworth

Phone+44 (0)28 9097 2307
Emailk.butterworthqub.acuk

Room 02.009 - PGJCCR
United Kingdom

Accepting PhD Students

PhD projects

Dr Butterworth is open to wide-ranging PhD applications from candidates with a basic science or clinical background.
His fields of interest include:
-Radiation Biology, Radiation Oncology and Cancer Imaging.
-Nanomedicine.
-Preclinical models and small animal radiotherapy.

Previous research experience is desirable although not essential.

Research activity per year

If you made any changes in Pure these will be visible here soon.

4 Finished

4 results

Filter

Finished

R5051CNR: Physical and biological characterisation of clinically relevant combined MRI-radiation exposures with conventional and nanoparticle contrast agents
Prise, K. & Butterworth, K.
27/09/2017 → 30/09/2020
Project: Research
R1709CNR: Physical and Biological characterisation of combined MRI radiation exposures with conventional and nanoparticle contrast agents.
Prise, K. & Butterworth, K.
04/01/2017 → 30/09/2020
Project: Research
R2231CNR: Assessment of tumour efficacy and normal tissue toxicity using AZD6738 in combination with radiotherapy for non-small cell lung cancer
Hanna, G., Butterworth, K. & Prise, K.
01/10/2015 → 31/03/2017
Project: Research
R5885CNR: Investigation of radiobiological efficacy of cannabinol derivatives
Butterworth, K. & Prise, K.
25/09/2015 → 29/02/2016
Project: Research

Karl Butterworth

Projects

Search results

R5051CNR: Physical and biological characterisation of clinically relevant combined MRI-radiation exposures with conventional and nanoparticle contrast agents

R1709CNR: Physical and Biological characterisation of combined MRI radiation exposures with conventional and nanoparticle contrast agents.

R2231CNR: Assessment of tumour efficacy and normal tissue toxicity using AZD6738 in combination with radiotherapy for non-small cell lung cancer

R5885CNR: Investigation of radiobiological efficacy of cannabinol derivatives